Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1436143306;43307;43308 chr2:178633192;178633191;178633190chr2:179497919;179497918;179497917
N2AB1272038383;38384;38385 chr2:178633192;178633191;178633190chr2:179497919;179497918;179497917
N2A1179335602;35603;35604 chr2:178633192;178633191;178633190chr2:179497919;179497918;179497917
N2B529616111;16112;16113 chr2:178633192;178633191;178633190chr2:179497919;179497918;179497917
Novex-1542116486;16487;16488 chr2:178633192;178633191;178633190chr2:179497919;179497918;179497917
Novex-2548816687;16688;16689 chr2:178633192;178633191;178633190chr2:179497919;179497918;179497917
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: S
  • RefSeq wild type transcript codon: TCC
  • RefSeq wild type template codon: AGG
  • Domain: Ig-94
  • Domain position: 43
  • Structural Position: 73
  • Q(SASA): 0.2328
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
S/C None None 1.0 N 0.743 0.451 0.300110245524 gnomAD-4.0.0 6.8571E-07 None None None None N None 0 0 None 0 0 None 0 0 0 0 1.6613E-05
S/Y None None 0.999 D 0.798 0.481 0.523806315272 gnomAD-4.0.0 1.37142E-06 None None None None N None 0 0 None 0 0 None 0 0 1.80224E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
S/A 0.1697 likely_benign 0.1596 benign -0.17 Destabilizing 0.994 D 0.463 neutral N 0.513416099 None None N
S/C 0.2732 likely_benign 0.2759 benign -0.159 Destabilizing 1.0 D 0.743 deleterious N 0.494021067 None None N
S/D 0.576 likely_pathogenic 0.5144 ambiguous 0.013 Stabilizing 0.998 D 0.601 neutral None None None None N
S/E 0.7888 likely_pathogenic 0.7786 pathogenic -0.098 Destabilizing 0.998 D 0.593 neutral None None None None N
S/F 0.3858 ambiguous 0.374 ambiguous -0.862 Destabilizing 0.999 D 0.781 deleterious D 0.596596037 None None N
S/G 0.1622 likely_benign 0.1437 benign -0.241 Destabilizing 0.998 D 0.423 neutral None None None None N
S/H 0.5418 ambiguous 0.5308 ambiguous -0.704 Destabilizing 1.0 D 0.745 deleterious None None None None N
S/I 0.4652 ambiguous 0.4617 ambiguous -0.117 Destabilizing 0.999 D 0.675 prob.neutral None None None None N
S/K 0.8841 likely_pathogenic 0.8745 pathogenic -0.38 Destabilizing 0.998 D 0.596 neutral None None None None N
S/L 0.1875 likely_benign 0.1918 benign -0.117 Destabilizing 0.999 D 0.643 neutral None None None None N
S/M 0.4267 ambiguous 0.4252 ambiguous 0.083 Stabilizing 1.0 D 0.749 deleterious None None None None N
S/N 0.3094 likely_benign 0.2673 benign -0.053 Destabilizing 0.998 D 0.603 neutral None None None None N
S/P 0.8488 likely_pathogenic 0.8471 pathogenic -0.108 Destabilizing 0.999 D 0.603 neutral D 0.593860501 None None N
S/Q 0.7958 likely_pathogenic 0.7838 pathogenic -0.324 Destabilizing 0.999 D 0.638 neutral None None None None N
S/R 0.86 likely_pathogenic 0.843 pathogenic -0.138 Destabilizing 0.999 D 0.612 neutral None None None None N
S/T 0.1446 likely_benign 0.1393 benign -0.16 Destabilizing 0.997 D 0.453 neutral N 0.428909299 None None N
S/V 0.4691 ambiguous 0.467 ambiguous -0.108 Destabilizing 0.999 D 0.702 prob.delet. None None None None N
S/W 0.6794 likely_pathogenic 0.6814 pathogenic -0.924 Destabilizing 1.0 D 0.759 deleterious None None None None N
S/Y 0.3978 ambiguous 0.3866 ambiguous -0.618 Destabilizing 0.999 D 0.798 deleterious D 0.596435872 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.